AREDS vs. AREDS 2: What Changed & Why It Matters

Introduction

When it comes to age-related macular degeneration (AMD), many people turn to supplements to help slow its progression. Age-Related Eye Disease Studies; AREDS and the AREDS 2 study (sometimes referred to as AREDS2 or AREDS-2) have played a crucial role in modern eye health supplementation. But what exactly changed between the original AREDS formula and AREDS 2, and why does it matter?

If you or a loved one are considering eye supplements, understanding the key differences between these two formulations can help you make the right choice. Let’s break down the science behind the updates and why AREDS 2 is now the recommended choice for those managing AMD.

Why Are We Talking About AMD First?

Before we dive into the differences between AREDS and AREDS 2, it’s important to understand why these formulations exist in the first place. Both AREDS and AREDS 2 were developed as a result of extensive research into age-related macular degeneration (AMD), a leading cause of vision loss in older adults. Studies were conducted to determine whether specific vitamins and minerals could help slow the progression of this condition. By first exploring what AMD is, who it affects, and how it progresses, we can better appreciate why AREDS and AREDS 2 are so significant for those looking to protect their vision.

Understanding Age-Related Macular Degeneration (AMD)

AMD is a progressive eye disease that affects the macula, the part of the retina responsible for central vision. It is one of the leading causes of vision loss in individuals over 50. AMD occurs in two forms:

• Dry AMD (Atrophic) – The most common type, accounting for 80-90% of cases. It results from the gradual breakdown of macular cells and the accumulation of drusen (small yellow deposits), leading to blurred central vision. Studies suggest that about 10-15% of people with dry AMD may progress to wet AMD over time.
• Wet AMD (Neovascular) – A more severe but less common form, caused by abnormal blood vessel growth under the retina, which can lead to rapid vision loss due to bleeding and fluid leakage. Currently, options are limited and involve injections in the eye.

Risk Factors for AMD

• Age: The primary risk factor, with prevalence increasing significantly after 50.
• Genetics: A family history of AMD increases susceptibility.
• Smoking: Smokers have a twice higher risk of developing AMD.
• Cardiovascular Health: Conditions such as high blood pressure and high cholesterol are linked to AMD progression.
• Diet & Lifestyle: Poor nutrition and obesity may contribute to AMD development.

Symptoms of AMD include:

• Blurred or fuzzy central vision
• Straight lines appearing wavy
• Difficulty recognising faces
• Dark or empty spots in central vision

Early diagnosis through regular eye exams is crucial, as early intervention can help slow progression.

What Was the Original AREDS Formula?

The National Eye Institute (NEI) conducted the first Age-Related Eye Disease Study (AREDS) in the 1990s to determine whether certain vitamins and minerals could help slow the progression of AMD.

The original AREDS formula included:

• Beta-carotene – 15 mg
• Vitamin C – 500 mg
• Vitamin E – 400 IU
• Zinc – 80 mg
• Copper – 2 mg (to balance high zinc intake)

Key Findings from AREDS

The study found that this combination of antioxidants and minerals reduced the risk of dry AMD progression by about 25% in people with moderate to advanced AMD. While the AREDS formula was beneficial, it also raised some concerns, particularly regarding beta-carotene.

Why Was AREDS Updated to AREDS 2?

Following the success of the first study, researchers launched AREDS 2 (2006-2013) to improve upon the original formula based on new scientific findings.

Key Changes in AREDS 2

The AREDS 2 formula introduced the following improvements:

✅ Beta-Carotene Removed & Replaced with Lutein + Zeaxanthin

• Beta-carotene was found to increase lung cancer risk in smokers, prompting its removal.
• Lutein (10 mg) and Zeaxanthin (2 mg) were added as safer, more effective carotenoids for eye health.

✅ Omega-3s Were Tested But Not Included

• Researchers examined whether DHA & EPA (omega-3 fatty acids) could further slow AMD progression.
• The results showed no significant benefit, so omega-3s were not included in the final AREDS 2 formula.

✅ Lower Zinc Option Introduced

• The original AREDS formula contained 80 mg of zinc, higher than recommended.
• AREDS 2 tested a reduced zinc level (25 mg) and found it to be equally effective for AMD.

AREDS vs. AREDS 2: Side-by-Side Comparison

How AREDS 2 Helps Manage AMD

AREDS 2 has been scientifically proven to help slow the progression of moderate-to-advanced AMD. The key nutrients in AREDS 2 work in the following ways:

• Lutein & Zeaxanthin: These carotenoids protect the retina from blue light damage and oxidative stress.
• Zinc & Copper: Essential for retinal cell function and reducing macular deterioration.
• Vitamins C & E: Antioxidants that help combat free radical damage in the eyes.

While AREDS 2 does not cure AMD, it plays a vital role in preserving vision and delaying further deterioration.

Final Thoughts: Which One is Right for You?

If you’re considering an eye supplement for AMD management, the research is clear:

• AREDS 2 is the safer, improved formula and the best option for long-term eye health.
• It removes the risks associated with beta-carotene and includes lutein & zeaxanthin, which offer stronger macular protection.
• If you’re still taking AREDS 1, switching to AREDS 2 is recommended for optimal benefits.

If you’re looking for a high-quality AREDS 2 supplement, make sure to choose one that follows the clinically tested formula for maximum effectiveness.

💡 Explore our AREDS 2-compliant supplements to support your vision health today.